Pictet Asset Management (Switzerland)’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,979
| Closed | -$203K | – | 2001 |
|
|
2023
Q1 | $203K | Buy |
+4,979
| New | +$203K | ﹤0.01% | 1722 |
|
|
2022
Q2 | – | Sell |
-67,470
| Closed | -$5.15M | – | 1655 |
|
|
2022
Q1 | $5.15M | Sell |
67,470
-703
| -1% | -$53.7K | 0.01% | 799 |
|
|
2021
Q4 | $4.1M | Sell |
68,173
-7,977
| -10% | -$480K | ﹤0.01% | 869 |
|
|
2021
Q3 | $4.26M | Buy |
+76,150
| New | +$4.26M | ﹤0.01% | 862 |
|